• intloko_ibhena_01

I-Orlistat 96829-58-2 Ukunciphisa i-Absorption ye-Sietary Fat, okukhokelela ekulahlekeni kobunzima

Inkcazelo emfutshane:

Inombolo ye-CAS: 96829-58-2

Ifomula yemolekyuli: C29H53NO5

Ubunzima bemolekyuli: 495.73

Inombolo ye-EINECS: 639-755-1

Ukujikeleza okuthe ngqo: D20-32.0°(c=1inchloroform)

Indawo yokubila: 615.9±30.0°C (Kuqikelelwe)

Ubuninzi: 0.976±0.06g/cm3(Kuxelwe kwangaphambili)

Iimeko zokugcina: 2-8°C

 


Iinkcukacha zeMveliso

Iithegi zeMveliso

Iinkcukacha zeMveliso

Igama I-Orlistat
Inombolo yeCAS 96829-58-2
Ifomula yemolekyuli C29H53NO5
Ubunzima bemolekyuli 495.73
Inombolo ye-EINECS 639-755-1
Indawo yokunyibilika <50°C
Ukuxinana 0.976±0.06g/cm3(Kuxelwe kwangaphambili)
Imeko yokugcina 2-8°C
Ifom Umgubo
Umbala Mhlophe
I-acidity coefficient (pKa) 14.59±0.23 (Kuxelwe kwangaphambili)

Izithethantonye

(S) -2-FORMYLAMINO-4-METHYL-PENTANOICACID(S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]-DODECYLESTER;RO-18-0647;(-)-TETRAHYDROLIPSTAN; I-ORMYL-L-LEUCINE(1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYLESTER;Orlistat(synthetase/compound);Orlistat(synthesis);Orlistat(FerMentation)

Isiphumo se-Pharmacological

Iipropati

Umgubo omhlophe wekristale, phantse awunyibiliki emanzini, unyibilika ngokulula kwiklorofomu, unyibilika ngokugqithisileyo kwi-methanol kunye ne-ethanol, kulula ukuyi-pyrolyze, indawo yokunyibilika yi-40℃~42℃. I-molecule yayo yi-diastereomer equkethe amaziko amane e-chiral, kubude be-wavelength ye-529nm, isisombululo sayo se-ethanol sinokujikeleza okungahambi kakuhle.

 

Indlela yokwenza

I-Orlistat yinto esebenza ixesha elide kunye neyona nto inamandla ye-gastrointestinal lipase inhibitor, eyenza i-enzymes ezimbini ezingentla apha ngokwenza i-covalent bond kunye ne-serine site esebenzayo ye-lipase esiswini kunye namathumbu amancinci. I-enzymes engasebenziyo ayikwazi ukuqhekeza amanqatha ekudleni kwi-fatty acids yamahhala kunye ne-Chemicalbook glycerol enokuthi ifakwe ngumzimba, ngaloo ndlela inciphisa ukutya kunye nokunciphisa ubunzima. Ukongeza, ezinye izifundo zifumene ukuba i-orlistat inqanda ukufunxwa kwamathumbu emathunjini e-cholesterol ngokuthintela i-niemann-pick C1-like protein 1 (niemann-pickC1-like1, NPC1L1).

 

Iimpawu

Le mveliso ngokudibanisa nokutya okuncinci kwe-hypocaloric kuboniswa kunyango lwexesha elide labantu abatyebileyo nabatyebileyo, kubandakanywa nabo banemingcipheko emiselweyo ehambelana nokukhuluphala. Le mveliso inokulawula ubunzima bexesha elide (ukulahleka kwesisindo, ukugcinwa kwesisindo kunye nokuthintela ukuphindaphinda) ukusebenza kakuhle. Ukuthatha i-orlistat kunokunciphisa imingcipheko enxulumene nokukhuluphala kunye neziganeko zezinye izifo ezinxulumene nokukhuluphala, kubandakanywa ne-hypercholesterolemia, uhlobo lwe-2 yeswekile, ukunyamezela kwe-glucose, i-hyperinsulinemia, i-hypertension, kunye nomxholo we-fat content.

 

Ukunxibelelana kwezamayeza

Inokunciphisa ukuxutywa kwamavithamini A, D kunye no-E. Inokuxhaswa kunye nale mveliso ngexesha elifanayo. Ukuba uthatha amalungiselelo aqukethe iivithamini A, D kunye ne-E (ezifana nezinye i-multivitamins), kufuneka uthathe le mveliso kwiiyure ezingama-2 emva kokuthatha le mveliso okanye ngexesha lokulala. Abantu abanesifo sikashukela sohlobo lwe-2 banokufuna ukunciphisa umthamo we-oral hypoglycemic agents (umzekelo, i-sulfonylureas). Ukusetyenziswa ngokubambisana kunye ne-cyclosporine kunokubangela ukuhla kwe-plasma concentrations yokugqibela. Ukusetyenziswa kunye ne-amiodarone kunokubangela ukunciphisa ukufunxa kokugqibela kunye nokunciphisa ukusebenza kakuhle.


  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo wakho apha kwaye uwuthumele kuthi